The clinically relevant intracranial murine glioma cell line KR158B was modified to express luciferase and gp100 (KR158B-Luc-gp100; Kluc-gp100), while retaining the high-grade glioma features of the parental cell line. The gene discussed is PMEL; the disease is central nervous system cancer.